Dr. John Mansueti is board certified in Radiation Oncology by the American Board of Radiology. He is currently treating patients in the Salisbury and Berlin locations of the Richard A. Henson Cancer Institute.
After graduating from the United States Naval Academy in the top 10% of his class, Dr. Mansueti initially served as a naval aviator prior to receiving his medical degree from the Uniformed Services University of Health Sciences. He completed an internship at National Naval Medical Center and attended United States Naval Flight Surgeon School in Pensacola, Florida. He completed a Residency in Radiation Oncology through the National Capital Consortium, serving as Chief Resident. He was the Clinical Chief of radiation oncology at the National Naval Medical Center in Bethesda Maryland prior to military retirement.
Dr. Mansueti is a member of the American Society for Radiation Oncology, American College of Radiation Oncology, American Brachytherapy Society, American College of Radiology, and the American Society of Clinical Oncology.
He has vast clinical experience in prostate brachytherapy, stereotactic body radiation therapy, gynecologic oncology, intensity modulated radiation therapy, and has a keen interest in prostate, lung, breast, gastrointestinal, and gynecologic cancers.
PRMC radiation oncology offers cutting edge radiation therapy treatment options including stereotactic body radiation therapy (SBRT), stereotactic radio-surgery (SRS), high dose rate brachytherapy (HDR), prostate brachytherapy, RapidArc intensity modulated radiation therapy with the most advanced technology including both Truebeam and Trilogy linear accelerators.
PRMC has multiple radiation oncology clinical trials open to provide our patients with advanced treatment options, as well as a cooperative agreement with Johns Hopkins Hospital for clinical research.